Home » GMP Audit Reports Available » Cipla Kurkumbh (Finished Product)

Cipla Kurkumbh (Finished Product)

- PharmAssess™ GMP Audit

About Cipla Ltd

Established in 1935, Cipla stands for The Chemical, Industrial, Pharmaceutical Laboratories. Head Office is based in Mumbai, with plants based in Bangalore, Vikhroli, Patalganga, Kurkumbh, Goa, Baddhi. Cipla is currently India’s second largest pharmaceutical Company in terms of sales and it produces a range of low-cost pharmaceutical ingredients (APIs), prescription drugs, OTC products, and formulations. Exports constitute approximately 50% of its sales and it markets products in more than 170 countries. Formulations accounted for 73% of Cipla’s exports in 2006 and APIs accounted for the remaining 27%.

About the Audit

The audit on Cipla Kurkumbh site was performed on 8 - 9 October 2007. The Audit Report includes photographs and is 39 pages long, excluding appendices. Including appendices the Report is 79 pages long.

Cipla Ltd manufactures a wide range of APIs and formulated products for the pharmaceutical industry worldwide, including the manufacture of Meloxicab tablets.

How to Purchase an Audit

Once you have decided which PharmAssess™ audit report(s) you require, purchasing a report is very simple:

  • A quotation will be sent to you for the purchase of the Audit Report(s) you require.
  • Rephine obtains auditee's approval for sale of the report.
  • Once approval of the Quotation is received we will dispatch the Audit Report, in CD format accompanied by an Invoice.
  • On receipt of payment the password to access the report is immediately issued

Purchase this Audit »


Ad-Hoc Audit Requirements

Please note that if there are other audits that you require, which are not in the PharmAssess Section of this website, please contact us to discuss your audit requirements, which we can undertake on your behalf.

Rephine has an ongoing programme of audits which is being constantly updated. If an audit you require is not on the list of those available, please contact the Rephine office to establish whether it is in the programme to be done or how it can be fitted in to the programme.

Commissioned GMP Auditing »


Further Information

If you require further information about the PharmAssess™ services offered by Rephine, or you would like to purchase an Audit Report, please contact us by email at enquiries@rephine.com or telephone 0044 1763 853135